Benchmarks trade with minor cuts; realty shares rise for third day

Image
Capital Market
Last Updated : Jan 18 2022 | 11:50 AM IST

The key equity barometers were trading with minor cuts in mid morning trade. The Nifty hovered around the 18,250 mark. Realty stocks extended gains for the third consecutive session.

At 11:26 IST, the barometer index, the S&P BSE Sensex, was down 190.12 points or 0.31% to 61,118.79. The Nifty 50 index lost 62.40 points or 0.34% to 18,245.70.

In the broader market, the S&P BSE Mid-Cap index shed 0.47% while the S&P BSE Small-Cap index declined 0.20%.

The market breadth was negative. On the BSE, 1454 shares rose and 1834 shares fell. A total of 99 shares were unchanged.

Buzzing Index:

The Nifty Realty index rose 0.33% to 517.80, extending gains for third day in a row. The index has added 2.78% in three sessions.

Brigade Enterprises (up 4.05%), Macrotech Developers (up 1.40%) and Sobha Developers (up 1.05%)advanced while The Phoenix Mills (down 2.56%) and Godrej Properties (down 0.76%) declined.

Prestige Estates gained 5.40% to Rs 540.10. The realty company's sales booking for Q3 increased by 110.6% to Rs 4267.6 crore, compared to Rs 2,026 crore recorded in Q3 last FY21.

Prestige Estates also posted its highest-ever quarterly collections in Q3 FY22, at Rs 2431.6 crore, up 70% YoY, a result of exemplary response from the company's newly launched projects, like Prestige Avalon, Aspen & Eden Park, Prestige Beverly Hills, Hyderabad and its existing inventories across geographies, noted the company's Chairman.

Stocks in Spotlight:

Tata Steel Long Products slipped 3.66% to Rs 793 after the company's net profit declined 65.8% to Rs 103.8 crore in Q3 FY22 from Rs 304.3 crore posted in Q3 FY21.

Tatva Chintan Pharma Chem slumped 7.89% to Rs 2641.65. The company reported a 9.2% increase in consolidated net profit to Rs 22.8 crore on a 31% jump in net sales to Rs 104.6 crore in Q3 FY22 over Q3 FY21. Sequentially, however, the company's net profit and net sales have declined by 29.7% and 15.4%, respectively.

On the BSE, 18,150 shares of Tatva Chintan Pharma were traded in the counter so far compared with average daily volumes of 8,834 shares in the past two weeks.

Global markets:

Most Asian stocks edged lower on Tuesday. Investors continuing to monitor the global economic recovery from COVID-19.

Chinese President Xi Jinping cautioned against a rapid rise in interest rates on Monday that could derail the global recovery from the coronavirus pandemic.

Meanwhile, the Organization of the Petroleum Exporting Countries, or OPEC, is due to release its monthly oil market report on Tuesday where traders are likely to watch for signs that global oil demand has been affected by the surge in Covid cases around the world.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 18 2022 | 11:28 AM IST

Next Story